Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US
PaperCitations, authors & open-access status
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 33 citations, 2021 year and hybrid oa status.
33
Citations
2021
Year
hybrid
OA Status